News from anaptysbio, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 03, 2014, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology

 AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, announced today that the U.S. Patent and Trademark...

Mar 13, 2014, 07:01 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio And TESARO Announce Strategic Immuno-Oncology Antibody Collaboration

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration...

Jan 10, 2014, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Development Of Novel anti-IL33 Therapeutic Antibody

 AnaptysBio, Inc., a privately-held therapeutic antibody company today announced the development of a first-in-class therapeutic antibody to...

Dec 17, 2013, 08:00 ET

AnaptysBio Announces Antibody Development Agreement With Momenta

 AnaptysBio, Inc., a privately-held therapeutic antibody company today announced the initiation of an antibody development program with...

Oct 17, 2013, 07:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Receives Allowance Of US Patent Covering Proprietary ABELmAb™ Libraries

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, announced today that it has received a Notice of Allowance...

Sep 24, 2013, 07:02 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Named a 2013 "Fierce 15" Winner

 AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced its selection by the editors of...

Aug 29, 2013, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Expands Immunotherapy Portfolio With Anti-PD-1 Antibody Combinations

 AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the expansion of its proprietary...

May 16, 2013, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract award from the U.S. government for the...

Dec 04, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Develops Novel Antibody Scaffold With Extreme Thermostability

 AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the publication of a novel full-length antibody...

Oct 18, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Expands Patent Portfolio with Issuance of U.S. Patent to In Vitro Somatic Hypermutation

AnaptysBio, Inc., a privately held therapeutic antibody company, today announced the issuance of Patent # 8,288,160 entitled "Activation...

Aug 08, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

Anaptysbio Expands Leadership Team With Addition Of Dr. Andrew J. Mcknight

 AnaptysBio, Inc., a privately held therapeutic antibody company, today announced the addition of Andrew J. McKnight, Ph.D. as Senior...

May 01, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Antibody Discovery Partnership With Gilead Sciences

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced an antibody discovery partnership with Gilead Sciences, Inc. to...

Apr 09, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Strategic Antibody Discovery Partnership With Celgene Corporation

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced a strategic partnership with Celgene Corporation to develop novel...

Mar 15, 2012, 10:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board

 AnaptysBio, Inc., a privately held therapeutic antibody company, today announced the addition of David L. Lacey, M.D. and Michael Gallatin,...

Jan 06, 2012, 10:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces New Strategic Antibody Discovery

 AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the initiation of new strategic alliances with two partners:...

Dec 05, 2011, 15:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Describes Technology for the Discovery and Optimization of Fully Human Antibodies in Original Research Publication

 AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the publication of original research describing the...